E Ballarini

Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review

Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis

Subclinical Hypothyroidism in Children: Normal Variation or Sign of a Failing Thyroid Gland?

Engineering precision nanoparticles for drug delivery

Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells

Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines

Thyroid function in childhood obesity and metabolic comorbidity

Human Mesenchymal Stem Cells as a Carrier for a Cell-Mediated Drug Delivery

2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children

Subclinical hypothyroidism in childhood

Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement

2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum

Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery

ESHRE guideline: recurrent pregnancy loss

Subclinical Hypothyroidism in Children: Normal Variation or Sign of a Failing Thyroid Gland?

Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity

In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism

Treatment With Thyroid Hormone

ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier

Thyrotropin-Stimulating Hormone Receptor Gene Analysis in Pediatric Patients with Non-Autoimmune Subclinical Hypothyroidism